FDA approves sickle cell disease treatment that uses ‘remarkable’ gene-editing technology
Modern medicine is one step closer to a possible cure for sickle cell disease. Following the UK's approval of the world's first gene-editing treatment for sickle cell disease on November 16th, the US Food and Drug Administration (FDA) also approved the same treatment on December 8th. “FDA approval of CASGEVY is extremely important,” said Reshma […]
